Seattle researchers uncover genetic drivers of aggressive prostate cancer; NCI awards $200K contract to BioMarker Strategies

> Researchers from the Fred Hutchinson Cancer Research Center and the University of Washington have found genetic triggers at play in aggressive forms of prostate cancer. Story

> The National Cancer Institute has awarded a $200,000 contract to BioMarker Strategies to fund the creation of a companion molecular diagnostic to match patients with the appropriate targeted cancer drugs. Report

> Researchers at the University of Cambridge have identified genes that could be used to guide treatment of patients with Crohn disease and ulcerative colitis. Item

> A group of scientists from UCLA and elsewhere have contributed to the discovery of gene variants that signal increased risk of schizophrenia and bipolar disorder. Release